DarioHealth provides a digital health platform that pairs connected devices and AI coaching for chronic condition and behavioral health care. DRIO reports earnings on Thu, Nov 12, 2026. Analyst consensus is Buy, based on the latest ratings from 3 firms (2 buy, 1 hold, 0 sell).
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 27 | BTIG | Initiated | Buy | |
| Aug 19 | Alliance Global Partners | Initiated | Buy | |
| Aug 12 | TD Cowen | Maintained | Hold |
Seasonality
How DRIO has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2016.
Whale Options Flow
90DNo whale options trades in DRIO in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether DRIO is in one of them and how their past DRIO trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered DRIO in an article yet. Here's the latest on the wider market.
About DarioHealth
DarioHealth offers a digital health platform for managing chronic conditions such as diabetes, hypertension, and obesity, along with behavioral health care. It combines connected devices cleared by the FDA that track health data with coaching powered by AI and access to virtual clinical care. Its customers include medium to large employers, health plans, and pharmaceutical companies, and it also sells directly to consumers. The company is based in New York.
- Headquarters
- New York, NY